Home - The Dermatology Digest

Advertisement

Exploring the Use of Lebrikizumab (Ebglyss, Eli Lilly and Company) in AD Patients With Darker Skin Tones Featuring Dr. Andrew Alexis

June 13, 2025

Survey: No Consensus on Post-Isotretinoin Acne Management

June 12, 2025

DermaSensor Cuts Physicians’ Missed Skin Cancers by Half

June 12, 2025

NICE Recommends Nemolizumab (Nemluvio, Galderma) for AD in England and Wales

June 12, 2025

Introducing JuveXO Aesthetics, a New Exosome-powered Skincare Line From JuveXO

June 11, 2025

Bimekizumab (Bimzelx, UCB) Shows Lasting Efficacy in Phase 3 PsA Study

June 11, 2025

Advertisement

Advertisement

Advertisement

Latest Issue

Latest Supplements

Advertisement

Digital Edition Archive